HARVARD BIOSCIENCE INC — Director's Dealing 2014

Jun 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-05-30

Reporting Person: Duchemin Jeffrey (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-30	Stock option (right to buy)	$4.12	A	300000	Acquired	2024-05-30	Common Stock, par value $0.01 per share (300000)	Direct

Footnotes

F1: The options vest in four equal installments on January 1, 2015, 2016, 2017 and 2018.